Strategies & Technologies Driving Drug Discovery to Market
Shedding Light on Molecules in Living Cells
October 5, 2007 3:25 pm | News | CommentsClemson University chemists have developed a method to improve the longevity of fluorescent nanoparticles that may help researchers track the motion of a single molecule as it travels through a living cell.
Blade Servers
October 5, 2007 1:39 pm | Product Releases | CommentsSGI Altix ICE 8200 is the first in a new line of bladed servers purpose-built to handle true HPC applications and large scaleout workloads.
Peak Analysis Software
October 5, 2007 1:35 pm | Product Releases | CommentsADInstruments launched Peak Analysis chart software module for use with PowerLab data acquisition systems that speeds analysis of peaks in waveform data.
EP-NIR Analyzers
October 5, 2007 1:24 pm | Product Releases | CommentsAspectrics manufactures a complete line of Infrared and Near Infrared spectrometers for both at-line and on-line process related applications.
High Performance Computing
October 5, 2007 1:18 pm | Product Releases | CommentsIBM announced the availability of Windows Compute Cluster Server 2003 for the IBM System Cluster 1350 to enable mid-market and enterprise clients to take advantage of high-performance cluster computing.
Ultrafiltration Cassettes
October 5, 2007 1:09 pm | Product Releases | CommentsPall Corp.’s Omega T- Series Membrane Cassettes are constructed with high-performance materials that reduce extractables to deliver high-purity biological solutions.
Phase III Trial for Chronic Renal Failure
October 5, 2007 12:56 pm | News | CommentsAffymax Inc. plans to initiate phase III clinical studies with Hematide in chronic renal failure patients following recent discussions with the FDA on the design of the clinical trial program.
CPN Study Announced
October 5, 2007 12:51 pm | News | CommentsEpiCept Corp. will study EpiCept NP-1 for the treatment of chemotherapy-induced peripheral neuropathy (CPN).
China and India Join Clinical Trial Registry
October 5, 2007 12:48 pm | News | CommentsThe World Health Organization (WHO) expanded its clinical trial registry platform to include trial registers from China and India.
Alzheimer’s Patch Recommended for Approval
October 5, 2007 12:44 pm | News | CommentsA patch that delivers Novartis’ Exelon, an Alzheimer’s disease medication, through the patient’s skin has been recommended for approval in the European Union.
Ring Out the Old . . .
October 5, 2007 12:08 pm | by Tanuja Koppal, PhD, Editor in Chief | Articles | CommentsRing Out the Old.....
Getting a Hand from Uncle Sam: Small Biotechs Find Alternative Funding
October 5, 2007 12:03 pm | by Gillian Robinson, Monika Oli, Ronald L. Hayes, and Kevin K.W. Wang, Banyan Biomarkers and the University of Florida | Articles | CommentsStart-up life sciences companies have an alternative to dwindling venture capital by seeking small business grants from federal granting agencies. The money is available for riskier studies, but the requirements are no less strict than those of private investors.
Do’s and Don’ts of Technology Transfer
October 5, 2007 11:56 am | Articles | CommentsCompanies looking to license new technologies and academics seeking to commercialize their research have different goals and viewpoints. Getting them to reach an agreement can be complicated. G&P Editors Sean Keating, Tanuja Koppal, and Bill Schu recently spoke with a panel of experts on technology transfer a
Hybrid Microplate Reader
October 5, 2007 11:35 am | Product Releases | CommentsBioTek Instruments’ new microplate instrumentation technology includes the Synergy 4 multi-detection microplate reader with a multi-mode reader that combines filter-based and quadruple monochromator-based fluorescence detection technology in one instrument.
Stronger Biotech Coaxes More Venture Cash
October 5, 2007 11:32 am | by Sean Keating, Managing Editor | Articles | CommentsWhile venture capital funding remains strong for biotechnology companies, most money tends to go to later rounds with lesser risk. Scientific advancements and creative funding sources are helping biotech entrepreneurs get their ventures off the ground. The first working draft of the human genome was completed in 2
